Skip to main content
. 2014 May 12;45(1):67–76. doi: 10.3892/ijo.2014.2440

Figure 2.

Figure 2.

Kaplan-Meier curves of recurrence-free survival in OPSCC patients according to (A) HPV DNA, (B) HPV mRNA and (C) p16INK4a overexpression. Recurrence-free survival was significantly better in HPV DNA-positive OPSCC patients than HPV DNA-negative OPSCC patients and in OPSCC patients with p16INK4a overexpression than in OPSCC patients without p16INK4a overexpression.